Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS)
INR 56.84
(0.0%)
INR 56.84
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 46.83 Million INR | 24.2% |
| 2022 | 37.71 Million INR | -42.47% |
| 2021 | 65.54 Million INR | 0.62% |
| 2020 | 65.14 Million INR | 12.44% |
| 2019 | 57.93 Million INR | -11.44% |
| 2018 | 65.41 Million INR | 5.9% |
| 2017 | 61.77 Million INR | 5.03% |
| 2016 | 58.81 Million INR | 356.18% |
| 2015 | 12.89 Million INR | 18.47% |
| 2014 | 10.88 Million INR | 3.56% |
| 2013 | 10.5 Million INR | 59.66% |
| 2012 | 6.58 Million INR | 131.88% |
| 2011 | 2.83 Million INR | -64.09% |
| 2010 | 7.9 Million INR | -2.46% |
| 2009 | 8.1 Million INR | -10.44% |
| 2008 | 9.05 Million INR | 90.17% |
| 2007 | 4.75 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 12.39 Million INR | -42.42% |
| 2023 FY | 46.83 Million INR | 24.2% |
| 2023 Q1 | 7.24 Million INR | 102.88% |
| 2023 Q3 | 19.07 Million INR | 143.14% |
| 2023 Q2 | 7.84 Million INR | 8.28% |
| 2023 Q4 | 21.51 Million INR | 12.79% |
| 2022 FY | 37.71 Million INR | -42.47% |
| 2022 Q4 | 3.57 Million INR | -27.77% |
| 2022 Q1 | 8 Million INR | 205.93% |
| 2022 Q2 | 21.19 Million INR | 164.87% |
| 2022 Q3 | 4.94 Million INR | -76.67% |
| 2021 Q2 | 28.43 Million INR | 13.35% |
| 2021 Q1 | 25.08 Million INR | 78.33% |
| 2021 Q3 | 19.48 Million INR | -31.5% |
| 2021 Q4 | -7.55 Million INR | -138.77% |
| 2021 FY | 65.54 Million INR | 0.62% |
| 2020 FY | 65.14 Million INR | 12.44% |
| 2020 Q1 | 13.58 Million INR | 36.46% |
| 2020 Q4 | 14.06 Million INR | -17.41% |
| 2020 Q3 | 17.03 Million INR | -7.72% |
| 2020 Q2 | 18.45 Million INR | 35.86% |
| 2019 Q3 | 14.02 Million INR | 8.12% |
| 2019 Q4 | 9.95 Million INR | -29.0% |
| 2019 Q1 | 20.99 Million INR | 185.41% |
| 2019 FY | 57.93 Million INR | -11.44% |
| 2019 Q2 | 12.96 Million INR | -38.22% |
| 2018 Q2 | 21.5 Million INR | 2.35% |
| 2018 Q1 | 21.01 Million INR | 157.45% |
| 2018 Q3 | 15.54 Million INR | -27.73% |
| 2018 FY | 65.41 Million INR | 5.9% |
| 2018 Q4 | 7.35 Million INR | -52.68% |
| 2017 FY | 61.77 Million INR | 5.03% |
| 2017 Q4 | 8.16 Million INR | -54.74% |
| 2017 Q3 | 18.03 Million INR | 9.13% |
| 2017 Q2 | 16.52 Million INR | -13.26% |
| 2017 Q1 | 19.05 Million INR | 41.91% |
| 2016 Q2 | 16.83 Million INR | 52.9% |
| 2016 Q3 | 17.54 Million INR | 4.23% |
| 2016 FY | 58.81 Million INR | 356.18% |
| 2016 Q4 | 13.42 Million INR | -23.49% |
| 2016 Q1 | 11.01 Million INR | 2984.31% |
| 2015 Q4 | 357 Thousand INR | -82.21% |
| 2015 FY | 12.89 Million INR | 18.47% |
| 2015 Q3 | 2 Million INR | -55.61% |
| 2015 Q2 | 4.52 Million INR | -24.76% |
| 2015 Q1 | 6 Million INR | 608.14% |
| 2014 Q4 | 848.56 Thousand INR | -44.54% |
| 2014 FY | 10.88 Million INR | 3.56% |
| 2014 Q1 | 5.78 Million INR | 330.98% |
| 2014 Q2 | 2.72 Million INR | -52.96% |
| 2014 Q3 | 1.53 Million INR | -43.77% |
| 2013 Q4 | -2.5 Million INR | -199.61% |
| 2013 FY | 10.5 Million INR | 59.66% |
| 2013 Q1 | 2.44 Million INR | 145.31% |
| 2013 Q2 | 8.05 Million INR | 230.15% |
| 2013 Q3 | 2.51 Million INR | -68.81% |
| 2012 Q3 | 2.86 Million INR | -42.22% |
| 2012 Q1 | 4.15 Million INR | 193.63% |
| 2012 FY | 6.58 Million INR | 131.88% |
| 2012 Q2 | 4.95 Million INR | 19.34% |
| 2012 Q4 | -5.38 Million INR | -288.18% |
| 2011 Q3 | 2.54 Million INR | 0.0% |
| 2011 Q4 | -4.43 Million INR | -274.3% |
| 2011 FY | 2.83 Million INR | -64.09% |
| 2010 FY | 7.9 Million INR | -2.46% |
| 2009 FY | 8.1 Million INR | -10.44% |
| 2008 Q4 | 1.47 Million INR | 0.0% |
| 2008 FY | 9.05 Million INR | 90.17% |
| 2007 FY | 4.75 Million INR | 0.0% |
| 2007 Q4 | 2.77 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sigachi Industries Limited | 571.8 Million INR | 91.809% |
| Ind-Swift Limited | 142.31 Million INR | 67.089% |
| Bajaj HealthCare Limited | -837.93 Million INR | 105.59% |
| Sakar Healthcare Limited | 116.7 Million INR | 59.869% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 99.852% |
| Innova Captab Limited | 943.45 Million INR | 95.036% |
| Divi's Laboratories Limited | 16 Billion INR | 99.707% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | 97.1% |
| Morepen Laboratories Limited | 961.59 Million INR | 95.129% |
| Mankind Pharma Limited | 19.12 Billion INR | 99.755% |
| Sequent Scientific Limited | -358.69 Million INR | 113.058% |
| Wanbury Limited | 559.56 Million INR | 91.63% |
| Laurus Labs Limited | 1.6 Billion INR | 97.083% |
| Nectar Lifesciences Limited | 49.95 Million INR | 6.233% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | 99.005% |
| Alembic Limited | 2.68 Billion INR | 98.256% |
| Hikal Limited | 696 Million INR | 93.271% |
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | 99.239% |
| Neuland Laboratories Limited | 3 Billion INR | 98.439% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 99.152% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.312% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 96.516% |
| Themis Medicare Limited | 435.23 Million INR | 89.239% |
| RPG Life Sciences Limited | 876.6 Million INR | 94.657% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 99.879% |
| Lupin Limited | 19.14 Billion INR | 99.755% |
| Amrutanjan Health Care Limited | 449.72 Million INR | 89.586% |
| Wockhardt Limited | -4.63 Billion INR | 101.012% |
| Vaishali Pharma Limited | 7.18 Million INR | -551.505% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | 97.841% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 79.149% |
| Jubilant Pharmova Limited | 771 Million INR | 93.925% |
| FDC Limited | 3.05 Billion INR | 98.465% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.916% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | 67.923% |
| Eris Lifesciences Limited | 3.91 Billion INR | 98.805% |
| Venus Remedies Limited | 284.9 Million INR | 83.561% |
| ZIM Laboratories Limited | 172.46 Million INR | 72.843% |
| Bliss GVS Pharma Limited | 754.54 Million INR | 93.793% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | 67.701% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | 98.975% |
| Shilpa Medicare Limited | 318.74 Million INR | 85.306% |
| Albert David Limited | 754.2 Million INR | 93.79% |
| Ajanta Pharma Limited | 8.16 Billion INR | 99.426% |
| Hester Biosciences Limited | 188.89 Million INR | 75.204% |
| Suven Pharmaceuticals Limited | 3 Billion INR | 98.44% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 100.825% |
| Gufic Biosciences Limited | 861.35 Million INR | 94.562% |
| Windlas Biotech Limited | 581.87 Million INR | 91.951% |
| Procter & Gamble Health Limited | 2 Billion INR | 97.67% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 151.629% |
| Granules India Limited | 4.05 Billion INR | 98.844% |
| Aarti Drugs Limited | 1.71 Billion INR | 97.268% |
| Bal Pharma Limited | 73.92 Million INR | 36.64% |
| Alkem Laboratories Limited | 17.95 Billion INR | 99.739% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.951% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | 94.98% |
| Medicamen Biotech Limited | 109.31 Million INR | 57.152% |
| Unichem Laboratories Limited | -704.74 Million INR | 106.646% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | 36.258% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -560.416% |
| Valiant Laboratories Limited | 3.19 Million INR | -1365.478% |
| Orchid Pharma Limited | 921.66 Million INR | 94.918% |
| Medico Remedies Limited | 82.9 Million INR | 43.508% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | 98.887% |
| Ipca Laboratories Limited | 5.47 Billion INR | 99.144% |
| Brooks Laboratories Limited | -195.91 Million INR | 123.906% |
| Syncom Formulations (India) Limited | 253.14 Million INR | 81.498% |
| Piramal Enterprises Limited | -16.83 Billion INR | 100.278% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.717% |
| NATCO Pharma Limited | 13.88 Billion INR | 99.663% |
| Suven Life Sciences Limited | -1.05 Billion INR | 104.457% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 123.741% |
| Strides Pharma Science Limited | -706.14 Million INR | 106.633% |
| Indoco Remedies Limited | 984.6 Million INR | 95.243% |
| Alpa Laboratories Limited | 167.76 Million INR | 72.082% |
| Lasa Supergenerics Limited | -217.3 Million INR | 121.553% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 101.21% |